Source: International Congress 2019 – Airway infection in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Sanchez-Carpintero Abad (Madrid, Spain), J. Zulueta (Pamplona, Spain), J. De Torres (Pamplona, Spain), A. Alcaide (Pamplona, Spain), P. Sánchez Salcedo (Pamplona, Spain), U. Montes (Pamplona, Spain), J. Quevedo (Madrid, Spain), G. Bastarrika (Pamplona, Spain), A. Campo Ezquibela (Pamplona, Spain). Prevalence and burden of bronchiectasis in a lung cancer screening program. 2902

Member's Comments

No comment yet.

Related content which might interest you: Prevalence of bronchiectasis in a lung cancer screnning program Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer Year: 2019 Prevalence and characterization of interstitial lung disease in a lung cancer screening program Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009 The efficacy of COPD detection by using a community-based annual screening program for lung cancer Source: Annual Congress 2012 - Methodology in epidemiologic research Year: 2012 The prevalence of undiagnosed COPD and approaches to promote early COPD diagnosis in lung cancer population Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 Spirometry and under-diagnosis of COPD in a lung cancer screening cohort Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer Year: 2021 Prevalence and clinical characteristics of lung cancer with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 321s Year: 2005 The prevalance of tuberculosis in patients with lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 73s Year: 2004 Prevalence of COPD in a lung cancer screening programme with low dose CT scan Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer Year: 2009 What is real prevalence of COPD in patients with lung cancer? Source: Annual Congress 2008 - Comorbidities in COPD Year: 2008 Interstital lung disease rates and risk factors in a UK lung cancer screening trial Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 Screening and diagnosis of lung cancer Source: Annual Congress 2013 –ERS/The Lancet/The Lancet Respiratory Medicine joint Lunchtime session on lung cancer Year: 2013 The burden of emphysema on lung cancer prognosis Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020 Interstitial lung diseases in a lung cancer screening trial Source: Eur Respir J 2011; 38: 392-400 Year: 2011 Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes Source: Eur Respir J 2010; 35: 146-151 Year: 2010 Incidence of lung cancer among COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 494s Year: 2005 Proportion of incident lung cancers that would have been eligible for a lung cancer screening program in Australia Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer Year: 2021 Emphysema, COPD and lung cancer screening. Update of an ongoing study Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012 Lung cancer screening in COPD patients. Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms Year: 2018 Diagnosing COPD and targeted lung cancer screening}, Source: Eur Respir J 2012; 40: 1063-1064 Year: 2012